Key facts
- It has raised $1.6M; the latest was Later Stage VC ($130K) in Jan 2026.
- Notable investors include Boost VC, Swissnex, AIT Startups, Biopole, DART Ventures — 16 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 16 names
- ·Watchlist + deal alerts for Impli
- ·The full record, as it builds
Funding rounds
No funding rounds for Impli are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Impli
Developer of a monitoring device designed to continuously track hormone levels in patients undergoing fertility treatments. The company's device monitors hormone levels directly from subcutaneous tissue to make informed treatment decisions, enabling healthcare providers to implement preventive measures before complications arise.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2019
- Employees
- 8
- Website
- impli.org/
- Ownership
- Privately Held (backing)
Impli doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Impli shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Impli in its N-PORT filings yet. We sweep new filings monthly.